p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.
about
Alveolar macrophage innate response to Mycobacterium immunogenum, the etiological agent of hypersensitivity pneumonitis: role of JNK and p38 MAPK pathwaysp38α MAP Kinase C-Terminal Domain Binding Pocket Characterized by Crystallographic and Computational AnalysesMechanistically probing lipid-siRNA nanoparticle-associated toxicities identifies Jak inhibitors effective in mitigating multifaceted toxic responses.Non-surgical chemotherapeutic treatment strategies for the management of periodontal diseases.Anti-inflammatory effects of α-galactosylceramide analogs in activated microglia: involvement of the p38 MAPK signaling pathway.p38 MAP Kinase Inhibition Reduces Propionibacterium acnes-Induced Inflammation in VitroSepsis: Something old, something new, and a systems view.Histone deacetylase inhibitor treatment attenuates MAP kinase pathway activation and pulmonary inflammation following hemorrhagic shock in a rodent model.Unique MAP Kinase binding sitesNovel host response therapeutic approaches to treat periodontal diseases.The MIF receptor CD74 in diabetic podocyte injury.LPS-induced MCP-1 expression in human microvascular endothelial cells is mediated by the tyrosine kinase, Pyk2 via the p38 MAPK/NF-kappaB-dependent pathway.Herbal medicinal products target defined biochemical and molecular mediators of inflammatory autoimmune arthritis.p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD.RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosisThe role of endothelial cell adhesion molecules P-selectin, E-selectin and intercellular adhesion molecule-1 in leucocyte recruitment induced by exogenous methylglyoxal.The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor.Anticytokine therapy for periodontal diseases: Where are we now?A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.Reduced limb length and worsened osteoarthritis in adult mice after genetic inhibition of p38 MAP kinase activity in cartilage.Development of a HTRF kinase assay for determination of Syk activity.Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: Involvement of inflammatory and apoptotic markers.Role of Molecular Interactions and Protein Rearrangement in the Dissociation Kinetics of p38α MAP Kinase Type-I/II/III Inhibitors.Tannerella forsythia-produced methylglyoxal causes accumulation of advanced glycation endproducts to trigger cytokine secretion in human monocytes.Conjunctival Inflammatory Gene Expression Profiling in Dry Eye Disease: Correlations With HLA-DRA and HLA-DRB1
P2860
Q23913437-1FFAB874-28DE-444F-973B-F12581309C0CQ27655779-5B4697EE-6BBC-44AA-97A7-1ED3A0EC4A37Q33393397-BEBC0965-2E6D-47DA-8F0B-9473EE2E44A6Q34910816-7C5DF45F-8C3B-4B33-B93F-265904D3687FQ35093530-7DF4F43E-8E23-4757-BB8C-E447E65F8196Q35217914-D3AA8E92-1C7F-42F1-8092-474EF97960B0Q35500956-3E442F45-669C-4B02-8960-0AB8840F0C03Q35535693-1E81409F-CF61-48D0-B9EE-90940EE7883AQ36494279-32CFA808-8BA9-4040-A76C-6D69A04F5D3CQ36703987-7CD3CD94-BB11-4845-A9D9-0B4DA5D21FA8Q37086644-C0E4F621-BB17-445A-880B-04445066DB5DQ37188649-20421CF7-FD59-44FF-A12C-41C04E71CFC2Q37813237-20F50CA9-EB32-4BB9-8524-6A798FD8B919Q37988188-D0AA5911-822E-4FBF-923C-ADA461EAD886Q38528738-883E19F4-1D98-4F7C-AB2A-15FFD280454AQ39334763-AA7018B4-7312-4CCD-BDCE-CAD2D138DD47Q39510138-1DA96DA9-08A2-4411-B697-C1A626C12FF5Q39841074-82DD3F75-896D-4E74-8BAA-6B791F07EDA6Q40177595-FDB65D30-3CF6-4354-B654-62B5B89A267BQ42150940-78E1C468-264C-49EB-8568-D05D4D8EF8ACQ42273265-3F5A11AC-1DAC-4693-8733-82860E824849Q42429995-6FD46D27-FACA-4929-8E7A-80B6B29FEA7DQ52331082-F851FD9B-64B7-4932-966F-3F4B89C0833DQ52638907-F9D47B15-8E00-4CDC-B2EA-F06DC951443BQ58122088-10939DA6-8A25-4ABB-B80E-9D315EDC8A19
P2860
p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.
@ast
p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.
@en
p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.
@nl
type
label
p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.
@ast
p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.
@en
p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.
@nl
prefLabel
p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.
@ast
p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.
@en
p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.
@nl
P2093
P1476
p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines
@en
P2093
P356
10.1016/S0079-6468(08)70091-2
P577
2001-01-01T00:00:00Z